Investor Relations

Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII) provides biological based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. As a leader in alternatives to conventional pesticides, MBII has a proven go-to-market strategy and remains on the cutting edge of developing the types of biological products in which today’s farmers are increasingly interested.

Third Quarter 2021 Results Conference Call

Wednesday, November 10, 2021

Marrone Bio Innovations will present Q3 Earnings Results via Conference Call and Webcast at 4:30 p.m. Eastern Time

Latest Video Update

August 2020

Newly appointed CEO, Kevin Helash, shares his background, what brought him to Marrone Bio Innovations and insights on the company's Q2 earnings results.

MBII Stock

Press Releases

Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina

January 6, 2022Press Releases

Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth

January 6, 2022Press Releases

Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warrant Overhang

December 16, 2021Press Releases

Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹

December 16, 2021Press Releases

Marrone Bio’s Next-Generation Product for Environmentally Sustainable Pest Control Demonstrates Substantial Yield Gains in 2021 Field Trials

December 8, 2021Press Releases

Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide

November 17, 2021Press Releases

Presentations & Interviews

See Presentations Library for more.

Settlement of Shareholder Derivative Lawsuits

Notice of Pendency of Proposed Settlement of Stockholder Derivative Action

Stipulation of Settlement